Global Biological Products Safety Testing Service Market Growth (Status and Outlook) 2023-2029

Global Biological Products Safety Testing Service Market Growth (Status and Outlook) 2023-2029

The global Biological Products Safety Testing Service market size is projected to grow from US$ 3502.1 million in 2022 to US$ 7808.8 million in 2029; it is expected to grow at a CAGR of 12.1% from 2023 to 2029.

United States market for Biological Products Safety Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Biological Products Safety Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Biological Products Safety Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Biological Products Safety Testing Service players cover Merck, Charles River Laboratories, Sartorius, Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell and WuXi Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.

LPI (LP Information)' newest research report, the “Biological Products Safety Testing Service Industry Forecast” looks at past sales and reviews total world Biological Products Safety Testing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Products Safety Testing Service sales for 2023 through 2029. With Biological Products Safety Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Products Safety Testing Service industry.

This Insight Report provides a comprehensive analysis of the global Biological Products Safety Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Products Safety Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Products Safety Testing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Products Safety Testing Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Products Safety Testing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Products Safety Testing Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Raw Materials
Viral Banks
Cell Banks
Others

Segmentation by application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological

Please note: The report will take approximately 2 business days to prepare and deliver.